Plain-English translation of NCT06882746 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This early-stage trial is testing a new medication called to see if it can help people with advanced cancers of the colon, rectum, stomach, or pancreas. The medication is designed to help your immune system recognize and fight cancer cells. Researchers are trying to find the right dose and delivery method that works best and is safe enough for future use.
People with advanced colorectal, gastric, or pancreatic cancers often have limited treatment options, especially if surgery isn't possible or previous treatments haven't worked. This medication represents a new approach by training the immune system to attack cancer, and this trial will help determine if it can be a viable option for these patients.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as an injection at least once every 3 weeks for as long as it helps you and you can tolerate it. You'll make regular visits to the study site, which will include some overnight hospital stays so doctors can monitor your health closely, run blood tests, and watch for any side effects. If you take the medication at home, you'll have daily phone check-ins with the research team. You'll also receive additional medications before and after treatment to help manage any side effects.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States